Research Focus
Research undertaken by the Cancer Control Group is conducted with a view to reducing the burden from cancer through identifying risk factors, then translating these research findings into policy and practice.
This includes research to identify the environmental and genetic factors that cause cancer, as well as research into early diagnosis, treatment and survival.
The group had two major areas of research focus: melanoma and skin cancer, and upper gastrointestinal neoplasia.
Gallery
Research Projects
Current Research Projects
QSkin – the world’s largest study of melanoma and skin cancer.
PROBE-Net – the Progression of Barrett’s Esophagus Network.
The Preventable Burden of Cancer Project.
Skin cancer risk predictors
Click the links below to learn more about your risk of melanoma and keratinocyte cancers.
Keratinocyte cancer
Personal risk score for developing a keratinocyte cancer in the next 3 years
Melanoma risk predictor
The Melanoma Risk Predictor is not intended to be used as a substitute for your doctor's advice. You should always consult your doctor if you think you might be at risk, particularly if you have noticed a new or changed skin lesion.
Research Team
Rebekah Cicero
Emma Davis
Jean Claude Dusingize
Julia Steinberg
Funding
- National Health and Medical Research Council
- Cancer Council Queensland
Further Information
Internal Collaborations
External Collaborations
- Mark Smithers, Princess Alexandra Hospital, Department of Surgery, Brisbane.
- Peter Soyer, School of Medicine, The University of Queensland.
- Kiarash Khosrotehrani, School of Medicine, The University of Queensland.
- Monika Janda, Queensland University of Technology, Institute of Health and Biomedical Innovation.
- Wayne Phillips, Peter MacCallum Cancer Centre, Melbourne.
- Andrew Barbour, School of Medicine, The University of Queensland.
- Reginald Lord, St Vincent’s Hospital, Sydney.
- David Watson, Flinders University Department of Surgery, Adelaide.
- Sanchia Aranda, Cancer Council Australia.
- Margaret Karagas, Dartmouth Medical School, Hanover, New Hampshire, USA.
- Magdalena Claeson, Sweden.
- Tamar Njisten and Loes Hollestein, Erasmus University, The Netherlands.
- Tom Vaughan, Fred Hutchinson Cancer Research Center, Seattle, USA.
- Rebecca Fitzgerald, University of Cambridge, UK.
- Doug Corley, Kaiser Permanente Research Division, San Francisco, California, USA.
- Christian Abnet, National Cancer Institute, Washingto DC, USA
- Dr Petra Lahmann, Germany.